జర్నల్ ఆఫ్ క్లినికల్ & ఎక్స్‌పెరిమెంటల్ న్యూరోఇమ్యునాలజీ

నైరూప్య

During the COVID-19 Pandemic and Neuromyelitis Optica Therapy, Treatment Options for Patients with Neuromyelitis Optica Spectrum Disorder

Uqbah Iqbal

Neuromyelitis Optica (NMO) or device disease is a central nervous system inflammatory disorder characterized by optic neuritis and transverse myelitis episodes. In 1894, a doctor in Lyon, France, named Eugene device, described the condition. Afterward, it was thought that there was no clinical involvement beyond the optic nerve and spinal cord and that the disorder might be a variant of Acute Disseminated Encephalomyelitis (ADEM) when monophasic and a variant of classic Multiple Sclerosis (MS) when relapsing. However, NMO cases have frequently been associated with symptoms in other neurological axes.